Growth Metrics

Conmed (CNMD) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn -67.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -67.56%
Dec 31, 2025 6.92%
Sep 30, 2025 4.85%
Jun 30, 2025 -32.73%
Mar 31, 2025 42.63%
Dec 31, 2024 -23.15%
Sep 30, 2024 11.00%
Jun 30, 2024 62.36%
Mar 31, 2024 856.98%
Dec 31, 2023 586.25%
Sep 30, 2023 78.14%
Jun 30, 2023 42.32%
Mar 31, 2023 -1,272.87%
Dec 31, 2022 -134.33%
Sep 30, 2022 21.21%
Jun 30, 2022 -45.33%
Mar 31, 2022 -98.53%
Dec 31, 2021 67.71%
Sep 30, 2021 -39.18%
Jun 30, 2021 518.87%
Mar 31, 2021 500.48%
Dec 31, 2020 -50.72%
Sep 30, 2020 -4.03%
Jun 30, 2020 -74.33%
Mar 31, 2020 194.92%
Dec 31, 2019 65.47%
Sep 30, 2019 741.19%
Jun 30, 2019 4.62%
Mar 31, 2019 -115.67%
Dec 31, 2018 18.70%
Sep 30, 2018 -67.60%
Jun 30, 2018 28.68%
Mar 31, 2018 63.56%
Dec 31, 2017 51.99%
Sep 30, 2017 -45.77%
Jun 30, 2017 -10.88%
Mar 31, 2017 192.39%
Dec 31, 2016 12.27%
Sep 30, 2016 81.21%
Jun 30, 2016 75.52%
Mar 31, 2016 -211.81%
Dec 31, 2015 -52.44%
Sep 30, 2015 -6.51%
Jun 30, 2015 29.89%
Mar 31, 2015 -13.02%
Dec 31, 2014 -6.09%
Sep 30, 2014 -52.05%
Jun 30, 2014 -55.39%
Mar 31, 2014 211.13%
Dec 31, 2013 -19.52%
Sep 30, 2013 8.93%
Jun 30, 2013 -31.06%
Mar 31, 2013 -28.27%
Dec 31, 2012 29.11%
Sep 30, 2012 -23.30%
Jun 30, 2012 31.37%
Mar 31, 2012 -63.14%
Dec 31, 2011 14.51%
Sep 30, 2011 273.56%